Equity
€6.0m ▼ 2.2%
DAXISPHARMA paid out €300,000 in dividends. That is 180% of the 2025 profit.
DAXISPHARMA
Lifetime
6 annual accounts with figures on one time axis, 45 filings since 1981peak €7.1m (2025)
€7.1m▲ 3.1%
peak €263,339 (2013)
€166,396▼ 18.7%
peak €8.0m (2013)
€6.0m▼ 2.2%
€19.2m▲ 99.3%
peak 44.1 FTE (2024)
43.9 FTE▼ 0.5%
Board15 names since 2014all names
4 directors and 3 others
Owners6 names in the annual accounts
99.57% and 5 others
Documentsfilings and deeds
10-03-202651 days before the deadline
2025financial year
3 directors reappointed, 1 statutory auditor reappointed 07-05Dividend €300,000Debts from €9.7m to €19.2mCash from €1.7m to €149,955
Key points
from the 2025 annual accounts, the last ones filedBoard and ownership
Managing director
Managing director
Director
Director
Director
Auditor,
- 100%score equity €50.3m (2025) · deed of 03-08-2026
- 99.57%annual accounts 30-09-2025
- consolidatesannual accounts 30-09-2025
Recent changes
Merger: absorbed by BENELUX
“inclusion des activités exercées par la société absorbée” (deed in French) · General meeting of 01-10-2026 · Gazette deed
Merger proposal: to be absorbed by Servier Benelux, SA
“objet modifié afin d'inclure les activités exercées par les Sociétés Absorbées, conformément à leurs objets…” (deed in French) · Servier Benelux, SA holds all the shares · Board meeting of 17-07-2026 · Gazette deed
3 directors reappointed
(managing director), and · General meeting of 04-03-2026 · Gazette deed
Registered office moved to Brussels
New registered office: Chaussée de Mons 1424, 1070 Bruxelles (Anderlecht) · Board meeting of 03-02-2026 · Gazette deed
Official details
Source: KBO- Status
- Absorbed by BENELUXmerger by absorption, October 2026
- Legal form
- Public limited company
- Activity
- “Toutes activités de nature civile, commerciale, financière, administrative, industrielle ou technique, en relation directe…” (deed in French)From the articles, 4 activitiesNo NACE code in the KBO yet
- Joint committee
- 200Auxiliary committee for white-collar workers · annual accounts 30-09-2025
- Financial year end
- 30 September
- Peppol
- Reachable since 14-10-2025
Annual accounts to 30-09-2025
- ≈ €12.0mestimated
- €25.2m▲ 59.9%
- Employeeson 30-09-2025
- 45▲ 2.3%
- Filing
- Filed on 10-03-2026
Companies linked to DAXISPHARMA
Shareholders
- 0.06%
Insights on DAXISPHARMA
Absorbed by BENELUX in October 2026. The last annual accounts are for financial year 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DAXISPHARMA
- What is the company number of DAXISPHARMA?
- The company number of DAXISPHARMA is 0420.720.276. The VAT number is the same number with BE in front: BE 0420.720.276.
- What is the legal form of DAXISPHARMA?
- DAXISPHARMA is a public limited company (NV).
- Is DAXISPHARMA still active?
- No. DAXISPHARMA is inactive in the KBO register.Company details
- How many employees did DAXISPHARMA have?
- DAXISPHARMA had an average of 43.9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does DAXISPHARMA fall under?
- In its 30-09-2025 annual accounts, DAXISPHARMA states joint committee 200 (Auxiliary committee for white-collar workers).
- What is the turnover of DAXISPHARMA?
- The turnover in financial year 2025 is ≈ €12.0m. This figure is estimated from the gross margin of €7.1m and 1,566 comparable companies of the same size. It probably lies between €8.2m and €20.0m. It is a rough estimate.
- Is DAXISPHARMA profitable?
- In financial year 2025, DAXISPHARMA made a profit of €166,396.
- Where can I find the annual accounts of DAXISPHARMA?
- DAXISPHARMA filed 45 annual accounts with the National Bank of Belgium, the latest for financial year 2025.